- Home
- GDTC vs OVID Comparison
GDTC vs OVID Comparison
Compare GDTC & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- OVID
- Stock Information
- Founded
- GDTC 2018
- OVID 2014
- Country
- GDTC Singapore
- OVID United States
- Employees
- GDTC N/A
- OVID N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- GDTC Health Care
- OVID Health Care
- Exchange
- GDTC Nasdaq
- OVID Nasdaq
- Market Cap
- GDTC 28.0M
- OVID 24.0M
- IPO Year
- GDTC 2023
- OVID 2017
- Fundamental
- Price
- GDTC $2.35
- OVID $0.29
- Analyst Decision
- GDTC Buy
- OVID Strong Buy
- Analyst Count
- GDTC 1
- OVID 6
- Target Price
- GDTC $5.00
- OVID $3.03
- AVG Volume (30 Days)
- GDTC 9.6K
- OVID 385.5K
- Earning Date
- GDTC 01-01-0001
- OVID 05-13-2025
- Dividend Yield
- GDTC N/A
- OVID N/A
- EPS Growth
- GDTC N/A
- OVID N/A
- EPS
- GDTC N/A
- OVID N/A
- Revenue
- GDTC $368,838.00
- OVID $548,000.00
- Revenue This Year
- GDTC $5.37
- OVID N/A
- Revenue Next Year
- GDTC N/A
- OVID $36.11
- P/E Ratio
- GDTC N/A
- OVID N/A
- Revenue Growth
- GDTC N/A
- OVID 15.61
- 52 Week Low
- GDTC $1.20
- OVID $0.24
- 52 Week High
- GDTC $4.05
- OVID $3.43
- Technical
- Relative Strength Index (RSI)
- GDTC 49.94
- OVID 42.88
- Support Level
- GDTC $2.26
- OVID $0.29
- Resistance Level
- GDTC $2.60
- OVID $0.33
- Average True Range (ATR)
- GDTC 0.13
- OVID 0.03
- MACD
- GDTC 0.00
- OVID 0.00
- Stochastic Oscillator
- GDTC 40.38
- OVID 22.36
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.